SEER data, corpus uteri cancer: Treatment trends versus survival for FIGO stage II, 1988-1994

Gynecologic Oncology

Volumn 74, Issue 3, 1999, Pages 350-355

  Cornelison, Terri L ^a,b   Trimble, Edward L ^a,b   Kosary, Carol L ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Adenocarcinoma; Corpus uteri cancer; FIGO II; Radical hysterectomy; SEER; Survival

Indexed keywords

ARTICLE; CANCER STAGING; CANCER SURVIVAL; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYSTERECTOMY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADICAL HYSTERECTOMY; SURVIVAL RATE; TREATMENT OUTCOME; UTERUS CANCER;

EID: 0032823991     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1999.5501     Document Type: Article

References (31)

1. Elia G, Garfinkel DA, Goldberg GL, Davidson S, Runowicz CD: Surgical management of patients with endometrial cancer and cervical involvement. Eur J Gynaecol Oncol 16:169-173, 1995
2. Maggino T, Romagnolo C, Landoni F, Sartori E, Zola P, Gadducci A: An analysis of approaches to the management of endometrial cancer in North America: a CTF study. Gynecol Oncol 68:274-279, 1998
3. FIGO News: Int J Gynecol Obstet 28:189-193, 1989
4. Mannel RS, Berman ML, Walker JL, Manetta A, DiSaia PJ: Management of endometrial cancer with suspected cervical involvement. Obstet Gynecol 75:1016-1022, 1990
5. Rutledge F: The role of radical hysterectomy in adenocarcinoma of the endometrium: Gynecol Oncol 2:331-347, 1974
6. Homesley HD, Boronow RC, Lewis JL Jr.: Stage II endometrial adenocarcinoma: Memorial Hospital for Cancer, 1949-1965. Obstet Gynecol 49:604-608, 1977
7. Bruckman JE, Goodman RL, Murthy A, Marck A: Combined irradiation and surgery in the treatment of stage II carcinoma of the endometrium. Cancer 42:1146-1151, 1978
8. Kinsella TJ, Bloomer WD, Lavin PT, Knapp RC: Stage II endometrial carcinoma: 10-year follow-up of combined radiation and surgical treatment. Gynecol Oncol 10:290-297, 1980
9. Madoc-Jones H: Adenocarcinoma of the endometrium, stage II: problems in definition and management. Int J Radiat Oncol Biol Phys 6:887-890, 1980
10. Parsons L, Cesare F: Wertheim hysterectomy in the treatment of endometrial carcinoma. Surg Gynecol Obstet 108:582-590, 1959
11. Randall CL: Letter to editor: panhysterectomy for uterine carcinoma. Am J Obstet Gynecol 59:942, 1950
12. Brunschwig A, Murphy A: Rationale for radical panhysterectomy and pelvic node excision in carcinoma of corpus uteri; clinical and pathological data on mode of spread of endometrial carcinoma. Am J Obstet Gynecol 68:1482-1488, 1954
13. Fletcher GH: Clinical dose-response curves of human malignant epithelial tumours. Br J Radiol 46:1-12, 1973
14. Copeland LJ: Update on endometrial cancer. Clin Obstet Gynecol 39:627-628, 1996
15. Onsrud M, Aalders J, Abeler V, Taylor P: Endometrial carcinoma with cervical involvement (stage II): prognostic factors and value of combined radiological-surgical treatment. Gynecol Oncol 13:76-86, 1982
16. Piver MS, Rutledge FN, Smith JP: Five classes of extended hysterectomy for women with cervical cancer. Obstet Gynecol 44:265-272, 1974
17. Ries LAG, Kosary CL, Hankey BF, Miller BA, Edwards BK (eds): SEER Cancer Statistics Review: 1973-1995, Bethesda, MD, National Cancer Institute, 1998
18. SEER Program: SEER Extent of Disease 1988 Codes and Coding Manual, Bethesda, MD, National Cancer Institute, NIH Publication 94-2313, April, 1994
19. SEER Program: Comparative Staging Guide for Cancer, Bethesda, MD, National Cancer Institute, NIH Publication 93-3640, 1993
20. SEER Program: SEER Program Code Manual, Bethesda, MD, National Cancer Institute, NIH Publication 94-1999, April, 1994
21. Ederer F, Axtell LM, Cutler SJ: The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr 6:517-521, 1961
22. Boothby RA, Carlson JA, Neiman W, Rubin MM, Morgan MA, Schultz D, Mikuta JJ: Treatment of stage II endometrial carcinoma. Gynecol Oncol 33:204-208, 1989
23. Tamura H, Nakai Y, Nagano T, Ohara A, Shibamoto T, Nakayama T, Ohnishi T, Wakutani K, Taniguchi F, Suzuki N, Ban C, Ozawa M: Treatment and prognosis of pT2 endometrial carcinoma. Nippon Sanka Fujinka Gakkai Zasshi (Acta Obstet Gynecol Jap) 43:315-320, 1991
24. Leminen A, Forss M, Lehtovirta P: Endometrial adenocarcinoma with clinical evidence of cervical involvement: accuracy of diagnostic procedures, clinical course, and prognostic factors. Acta Obstet Gynecol Scand 74:61-66, 1995
25. Boente MP, Yordan EL Jr, McIntosh DG, Grendys EC Jr, Orandi YA, Davies S, Beck D, Graham JE Jr, Miller A, Marshall R, Dolan T, Kirschner C, Reddy S, Wilbanks GD: Prognostic factors and long-term survival in endometrial adenocarcinoma with cervical involvement. Gynecol Oncol 51:316-322, 1993
26. Berman ML, Ali Afridi M, Kanbour AI, Ball HG: Risk factors and prognosis in stage II endometrial cancer. Gynecol Oncol 14:49-61, 1982
27. Carl UM, Bahnsen J, Edel B, Chandra A: The value of a postoperative radiation therapy in FIGO stage I and II endometrial cancers. Strahlenther Onkol 171:322-325, 1995
28. Roberts JA, Brunetto VL, Keys HM, Zaino R, Spirtos NM, Bloss JD, Pearlman A, Maiman MA, Bell JG: A phase III randomized study of surgery versus surgery plus adjunctive radiation therapy in intermediate risk endometrial adenocarcinoma (GOG 99). Society of Gynecologic Oncologists 29th Annual Meeting, Orlando, FL, Abstract 35, 1998
29. Lanciano RM, Curran WJ Jr, Greven KM, Fanning J, Stafford P, Randall ME, Hanks GE: Influence of grade, histologic subtype, and timing of radiotherapy on outcome among patients with stage II carcinoma of the endometrium. Gynecol Oncol 39:368-373, 1990
30. Nori D, Hilaris BS, Tome M, Lewis JL Jr, Birnbaum S, Fuks Z: Combined surgery and radiation in endometrial carcinoma: an analysis of prognostic factors. Int J Radiat Oncol Biol Phys 13:489-497, 1987
31. Bucy GS, Mendenhall WM, Morgan LS, Chafe WE, Wilkinson EJ, Marcus RB Jr, Million RR: Clinical stage I and II endometrial carcinoma treated with surgery and/or radiation therapy: analysis of prognostic and treatment-related factors. Gynecol Oncol 33:290-295, 1989